Gilead Sciences (GILD) PT Lowered to $168 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $125.15 +0.08%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 44
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 44
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn lowered the price target on Gilead Sciences (NASDAQ: GILD) to $168.00 (from $175.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
- JPMorgan Upgrades Japan Post Insurance Co., Ltd (7181:JP) (JPPIF) to Overweight
- Dai-ichi Life Holdings, Inc (8750:JP) (DCNSF) PT Raised to JPY1,900 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
